Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zetia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

Merck hopes for another Keytruda with new immunotherapy deal

Merck hopes for another Keytruda with new immunotherapy deal But Merck has been hit by the on-going erosion to its cardiovascular and cholesterol drugs Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin). ... This is primarily due to loss of exclusivity of Zetia in Canada and declines of both products in the US.

Relief as study finds no cardiovascular risk with Januvia

Relief as study finds no cardiovascular risk with Januvia Overall pharma sales fell 2% on the back of declines for cholesterol drugs Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin) as well as immunotherapeutic Remicade (infliximab) which is facing biosimilar competition in

PCSK9 inhibitor alirocumab works in statin-intolerance

PCSK9 inhibitor alirocumab works in statin-intolerance Sanofi and Regeneron’s drug impresses at American Heart Association meeting. Sanofi and Regeneron's investigational drug alirocumab is more effective at reducing cholesterol levels than Merck &Co's Zetia in ... results of the IMPROVE-IT trial have now

Merck's ezetimibe has 'modest' benefit when added to statins

Merck's ezetimibe has 'modest' benefit when added to statins Vytorin and ezetimibe monotherapy Zetia got off to a strong start in the market but were quickly enveloped in controversy when the results of another study - called ENHANCE - failed to show ... Undeterred, Merck has said it will now file for approval of

Sanofi and Regeneron pay $67.5m to speed alirocumab review

Sanofi and Regeneron pay $67.5m to speed alirocumab review phase III trials, outperforming rival drug Zetia (ezetimibe) from Merck &Co as a monotherapy.  .

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics